TIA SCHMIDT: Open Payments
NPI 1710688114 · CHILLICOTHE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 28 payments from 12 companies in 2025. Trend: 2023 $544 · 2024 $647 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $135 |
| AstraZeneca Pharmaceuticals LP | 6 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Novo Nordisk Inc | 2 | $37 |
| PFIZER INC. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: VRAYLAR, AIRSUPRA, QULIPTA, XIFAXAN, UBRELVY, NURTEC ODT, BREZTRI, Veozah.
Industry payments across OH — which companies pay providers there.
